TGM6 and myeloid sarcoma: As an autoimmune target, anti-TGM6 antibodies were presented at a higher level in patients with progressive multiple sclerosis (MS)34, amyotrophic lateral sclerosis35, and gluten-sensitive cerebellar ataxia36,37.